Joe Vockley, Ph.D.
Chief Scientific Officer and Chief Operations Officer
Inova Translational Medicine Institute, Inova Health Systems
Joe Vockley received a BS in microbiology from The Pennsylvania State University, a Ph.D. in Molecular Genetics from The University of Delaware and completed a 3 year clinical genetics residency and post-doctoral fellowship at The University of California at Los Angeles (UCLA)/Cedars Sinai Medical Center.
He has 30+ years of experience in genetic, genomic and bioinformatics research in academia, the biotechnology sector, pharmaceutical companies and the US Government.
While at GlaxoSmithKline, Dr. Vockley led a team of discovery scientists for diagnostic and therapeutic cancer gene targets from the Human Genome Sciences EST database and was key to starting a new genetic testing facility. Dr. Vockley was Vice President of Genomics at Gene Logic Inc where he was responsible for building a biobank, a large-scale cancer gene expression database used for target discovery and a cancer diagnostic laboratory. While at Science Applications International Corporation (SAIC) he directed a bioinformatics tool development group and a laboratory group dedicated to the discovery and validation of molecular diagnostic targets.
At the National Cancer Institute, Dr. Vockley was the director of The Cancer Genome Atlas project.
He is currently the Chief Scientific Officer and Chief Operations Officer of the Inova Translational Medicine Institute.
Dr. Vockley is inventor on numerous patents for genetic discoveries, molecular genetic laboratory methods and bioinformatics tools and has published in the fields of metabolic disease and cancer.